Stocks
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -354.7% | -152.3% | -3 699% | -1 435% | -1 327% | |||
| Changes by years, y/y, % | +29pp | +202pp | +152pp | +2 264pp | +30.2% | ||||
Agios Pharmaceuticals. EBITDA margin, %
Agios Pharmaceuticals. EBITDA margin, changes, pp
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -1 615% | -1 396% | -1 364% | -1 476% | -1 108% | -1 327% | |
| Changes by years, y/y, % | +10 569pp | +361pp | +1 297pp | +3 749pp | +508pp | |||
| Changes by quarters, q/q, % | +3 610pp | +219pp | +32pp | -113pp | +369pp | |||
